A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation - Summary - MDSpire

A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation

  • By

  • Hamza A. Salim

  • Sarimar Agosto

  • Heba Al Qudah

  • Kim Learned

  • Mark Zafereo

  • Jennifer Wang

  • Mimi I. Hu

  • Ahmed Msherghi

  • Naifa Busaidy

  • F. Eymen Ucisik

  • Sarah Hamidi

  • Hussein Tawbi

  • Rami W. Eldaya

  • Jing Li

  • Max Wintermark

  • Maria E. Cabanillas

  • April 14, 2026

  • 0 min

Share

Objective:

To develop and validate a prognostic grading system for patients with brain metastases from differentiated thyroid carcinoma (DTC), addressing the significant gaps in existing prognostic models.

Key Findings:
  • Brain metastases from DTC are rare, with an incidence of 0.1–1.3%.
  • Median overall survival after diagnosis of brain metastases varies widely, from 3 to 60 months, highlighting the need for effective prognostic tools.
  • The DTC-GPA incorporates key prognostic factors to predict survival outcomes in patients with brain metastases, potentially improving clinical decision-making.
Interpretation:

The DTC-GPA provides a standardized approach to predict outcomes for DTC patients with brain metastases, addressing the lack of existing models specific to this population and offering a comparison to traditional prognostic systems.

Limitations:
  • The study is retrospective, which may introduce biases in data interpretation.
  • Data were collected from a single institution, potentially limiting generalizability to broader populations.
  • The rarity of brain metastases in DTC may affect the robustness of the findings and their applicability in clinical settings.
Conclusion:

The DTC-GPA is a novel prognostic tool that can aid in clinical decision-making for patients with brain metastases from differentiated thyroid carcinoma, potentially improving patient outcomes.

Original Source(s)

A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation

  • by Hamza A. Salim, Sarimar Agosto, Heba Al Qudah, Kim Learned, Mark Zafereo, Jennifer Wang, Mimi I. Hu, Ahmed Msherghi, Naifa Busaidy, F. Eymen Ucisik, Sarah Hamidi, Hussein Tawbi, Rami W. Eldaya, Jing Li, Max Wintermark, Maria E. Cabanillas

  • April 14, 2026

Related Content

Papillary thyroid carcinoma with brain and lung metastases: a case report

Venous Thromboembolism and Secondary Outcomes of Bleeding and Mortality in Patients with Gliomas: A Multicenter Cohort Study

CMRA-DETR: A Lightweight and High-Accuracy Detection Framework for MRI-Based Brain Tumor Identification